Corrigendum to "HIV remission trial investigators' attitudes towards risk and risk mitigation in trials that include treatment interruption" [J Virus Erad 9 (2) (June 2023) 100331]
Saved in:
Main Authors: | Eunice Akinyi Okumu (Author), Gail E. Henderson (Author), Carol Golin (Author), Kriste Kuczynski (Author), Nuchanart Q. Ormsby (Author), Holly L. Peay (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
HIV remission trial investigators' attitudes towards risk and risk mitigation in trials that include treatment interruption
by: Eunice Akinyi Okumu, et al.
Published: (2023) -
53 Perceptions of HIV remission ("cure") trials and trial intentions among potential participants treated in acute HIV infection
by: H. Peay, et al.
Published: (2016) -
What motivates participation in HIV cure trials? A call for real-time assessment to improve informed consent
by: Holly L. Peay, et al.
Published: (2015) -
How do HIV cure trial researchers respond to an embedded social science study?
by: H. Peay, et al.
Published: (2019) -
Partner protections in HIV cure-related trials involving analytical treatment interruption: Updated toolkit to mitigate HIV transmission risk
by: Karine Dubé, et al.
Published: (2024)